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Abstract
Maternal deprivation (MD) during neonatal life has diverse long-term behavioral effects and
alters the development of the hippocampus and frontal cortex, with several of these effects
being sexually dimorphic. MD animals show a marked reduction in their circulating leptin
levels, not only during the MD period, but also several days later (PND 13). A neonatal leptin
surge occurs in rodents (beginning around PND 5 and peaking between PND 9 and 10) that
has an important neurotrophic role. We hypothesized that the deficient neonatal leptin sig-
naling of MD rats could be involved in the altered development of their hippocampus and
frontal cortex. Accordingly, a neonatal leptin treatment in MD rats would at least in part
counteract their neurobehavioural alterations. MD was carried out in Wistar rats for 24 h on
PND 9. Male and female MD and control rats were treated from PND 9 to 13 with rat leptin
(3 mg/kg/day sc) or vehicle. In adulthood, the animals were submitted to the open field,
novel object memory test and the elevated plus maze test of anxiety. Neuronal and glial
population markers, components of the glutamatergic and cannabinoid systems and
diverse synaptic plasticity markers were evaluated by PCR and/or western blotting. Main
results include: 1) In some of the parameters analyzed, neonatal leptin treatment reversed
the effects of MD (eg., mRNA expression of hippocampal IGF1 and protein expression of
GFAP and vimentin) partially confirming our hypothesis; 2) The neonatal leptin treatment,
per se, exerted a number of behavioral (increased anxiety) and neural effects (eg., expres-
sion of the following proteins: NG2, NeuN, PSD95, NCAM, synaptophysin). Most of these
effects were sex dependent. An adequate neonatal leptin level (avoiding excess and defi-
ciency) appears to be necessary for its correct neuro-programing effect.
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Introduction
Increasing evidence gives support to the fact that early-life stress induces permanent alterations
in neurodevelopment [1] that may increase the risk of psychopathology at adulthood [2–4].
Manipulation of mother infant interactions has been extensively used as animal models of
early-life stress [5]. Notably, among these models, maternal deprivation (MD), 24 h at postna-
tal day (PND) 9, has been used as an animal model of early-life stress highly suitable for the
investigation of the developmental origin of certain psychiatric disorders such as schizophrenia
and depression [6, 7]. MD has been reported to provoke behavioral abnormalities that resem-
ble psychotic-like symptoms such a disruption in the pre-pulse inhibition (PPI) response [6,
8], neuroendocrine alterations related to stress reactivity [9–11], as well as cognitive impair-
ments in adult animals [12]. Studies have also described deviant behaviors in maternally
deprived adolescent animals, i.e. depressive-like responses [13] and increased impulsivity [14],
as well as cognitive impairment [15]. In addition to these long-term behavioral outcomes, sev-
eral short and long term brain alterations have been found, affecting neurons and glial cells,
growth factors and diverse synaptic plasticity proteins in the hippocampus, cerebral cortex and
hypothalamus of MD rats [16]. It is unclear how MD can modify these parameters since there
are numerous stressors included in the MD protocol such as lack of maternal care and nutri-
ents during the entire deprivation period, dehydration, and also a decrease of body temperature
in MD pups [17–19]. One of the most striking effects of MD is the marked reduction in circu-
lating leptin levels, not only during the maternal separation period (PND 9–10), but also sev-
eral days after (PND 13) and in the adulthood [16].
Leptin, an adipokine produced mainly by adipocytes, is a pleiotropic hormone involved in
many physiological processes such as food intake and energy balance, immune system func-
tions, reproduction, reward, stress and neurodevelopment [20–22]. Regarding this latter role,
there is a postnatal leptin surge in rodents, beginning around postnatal day (PND) 5 in males
and peaking between PND9 and 10 [23], that has been implicated in hypothalamic develop-
ment by modifying neuronal outgrowth and synaptic connectivity, as well as neurogenesis and
neuronal and glial survival [24]. Though most of the work on the physiological role of this neo-
natal leptin signaling has focused on hypothalamic development [24–27], it is likely that it has
also a crucial role on the development of other brain areas such as the hippocampus and the
frontal cortex. There is ample evidence that supports this hypothesis. The leptin receptor
(LepR) is expressed not only in the hypothalamus, but also in many other brain regions includ-
ing the cortex, amygdala, cerebellum, brain stem, substantia nigra, hippocampal CA1, CA3
areas and dentate gyrus (DG) in rodents and humans [28–30]. Leptin receptors are present on
the soma and proximal dendrites at presynaptic terminals of hippocampal neurons, as well as
on hippocampal astrocytes [31, 32], and there is good evidence indicating a neurothropic and
morphothropic role of leptin in this brain region [29, 30, 33–35]. The cortex also expresses
high levels of LepRb mRNA during development [36, 37] and leptin deficiency results in a
reduction in the number of cortical neurons born during embryonic life [38]. Leptin also
appears to influence axonal growth in the developing cortex since it causes a marked increase
in expansion of the axonal growth cone of primary cultures of embryonic cortical neurons.
Leptin is also involved in the development of non-neuronal cells in the cortex and may influ-
ence the development of oligodendroglial cells [39].
As circulating leptin levels are dramatically reduced during MD, we hypothesized that exog-
enous leptin treatment would normalize at least some of the long-term effects on the hippo-
campus and cerebral cortex, as well as some of the behavioral alterations seen in adult MD rats.
The aim of this study was to determine if a daily leptin treatment, between PND9 to PND13,
could protect from deleterious effects of MD or palliate in any way some of changes induced by
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the MD protocol. We looked at behavioral and molecular parameters that we had previously
analyzed and that were modified by MD [40]. Notably, important sex differences have been
consistently described in relation to both the behavioral and neurobiological consequences of
MD. Indeed, sex differences have been reported from early neonatal stages (PND 13) to adult-
hood [16]; thus, we have included both males and females in this study.
Materials and Methods
Animals
Adult Wistar rats were purchased from Harlan Interfauna Ibérica S.A. (Barcelona, Spain) and
allowed to acclimate for 2 weeks before mating. One male was placed in a cage with two females
for 10 days. On the day of birth (PND0), litters were culled to eight pups per dam (four males
and four females). No cross-fostering was employed. In all experimental groups three different
litters were used to reduce the litter effect, with a total of 12 rats in each experimental group.
Rats were maintained at a constant temperature (22 ± 1°C) and humidity (50 ± 2%) in a
reversed 12-h light-dark cycle (red light on at 08:00 and white light on at 20:00) and given free
access to rat chow (commercial diet for rodents 2918; Harlan Laboratories, Madison, WI,
USA) and water.
Experiments were approved by the local Animal Ethics Committee (Animal Research Com-
mitte of the Complutense University of Madrid), and were designated and performed in com-
pliance with the Royal Decree 1201/2005, October 21, 2005 (Boletín Oficial del Estado,BOE n°
252) about protection of experimental animals, and the European Communities Council Direc-
tive of 24 November 1986 (86/609/EEC). The experiments were approved by the Animal
Research Commitee of the Complutense University, reference number of the Protocol approval
document: CA UCM 5 2012. Animals were sacrificed by decapitation
Maternal deprivation
A summary of the experimental design can be seen in Fig 1. Maternal deprivation was per-
formed as previously described [13]. Briefly, beginning at 09:00 on PND9, mothers from the
deprived group were removed and placed in a cage beside the home cage in the same room. On
PND10, mothers were returned to the cage of their respective litters. Mothers of the control lit-
ters were left undisturbed.
Leptin treatment
From PND9 until PND13 rats were injected sc with 3 mg/kg bodyweight (bw) of rat leptin
(National Hormone& Pituitary Program, Torrance, CA). This dose was chosen on the basis of
a previous study by our own group [41]. The animals received one injection per day at 9:00.
Control rats were injected with the same volume (2.5 ml/kg) of vehicle (saline + 0.1% BSA).
After all the pups of the litter were injected they were returned to their mother. All rats were
left undisturbed until they were weaned at PND22, and at this time they were separated and
placed 2 rats of the same sex and experimental group/cage. Each experimental group consisted
of 12 animals from three different litters (4 animals/litter).
Behavioral testing
All animals were submitted to the behavioral tests, and only the animals that did not fulfill the
test requirements were excluded from the statistical analyses.
Open field test (OF). The open field test (OF) was performed in a square arena (60 cm x
60 cm x 45 cm) with matte-painted metallic walls and a plastic-covered wooden floor divided
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into 36 squares (10 cm x 10 cm) by white painted lines. On PND67 the animal’s general activity
was evaluated by video-recording (Sony DCR-DVD310E) observation as open field (OF) test.
Total ambulation (horizontal motor activity) was calculated as peripheral (by the walls) and
internal (by the squares not adjacent to the walls) line crossings. Rearing frequency (vertical
motor activity) and percentage of internal ambulation, considered as an index of emotionality
[42] and calculated as the percentage of internal ambulation refereed to total ambulation
[(internal line crossings/total line crossings) x 100], were also analyzed.
For the statistical analyses we used between 10–12 males and females per experimental
group from 3 different litters (3–4 animals/litter/experimental group). Two MDLept males and
2 CoLept females were excluded from the statistical analyses because there were some troubles
with videotape recorder.
Novel object test (NOT). The novel object test (NOT) was performed in the same appara-
tus used for OF. The test was performed as previously described [43] with some minor modifi-
cations [44]. Animals were allowed to freely explore the arena, under dim light conditions, for
5 min during 3 consecutive days (habituation period). On the test day (PND70), rats were first
exposed to two identical objects (two plastic boxes) during a 3 min training session. Rats were
then exposed, following a 4 h inter-trial interval, to one of the previously encountered objects
(familiar object, F1 or F2) and to a novel, non-familiar object (metallic colored box, N) in the
test session. Objects were not bigger than twice the size of a rat, and were located in contiguous
corners, at a distance of 10cm from the walls. For each animal, the positions of the objects were
not changed between the training and the test session. However, the objects’ positions were
changed between animals in order to avoid spatial preference.
Both training and test sessions were video recorded (Sony DCR-DVD310E), and animal’s
behavior was later evaluated by an experienced observer by means of an event-recorder
Fig 1. Experimental design diagram.
doi:10.1371/journal.pone.0137283.g001
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software (The Observer XT 11, Noldus, Wageningen, Netherlands). Time spent exploring
the objects during the two sessions was registered. Exploration of an object was considered
whenever animals pointed their nose toward an object at a maximum distance of 1 cm,
whereas turning around, climbing and/or biting the objects were not considered as explora-
tion [45]. In the test session, the discrimination index (DI) was calculated as the difference
between the time spent exploring the novel object (N) and the familiar one (F1 or F2) in rela-
tion to the total time spent exploring the objects [(N - F)/(N + F)]. Animals that explored the
two objects less than 10 s during the training and/or the test session were excluded from the
statistical analysis, as were animals that explored one of the objects less than 1 s during the
test session. Since an animal’s capacity to discriminate between the novel and the familiar
objects diminishes with time [45, 46], and in the present conditions animals explored the
objects during the first minute more than half the time spent in exploration during the whole
testing session, data from the first minute of the test session were employed for the statistical
analyses.
For the statistical analyses we used between 8–12 males and females per experimental group
from 3 different litters (3–4 animals/litter/experimental group). Two CoLept males, 1 MDVh
male, 4 MDLept males, and 2 CoLept females were excluded from the statistical analyses since
they did not fulfill the test requirements.
Elevated plus-maze (EPM). The elevated plus-maze (EPM) was formed by two open
arms (50 cm x 10 cm) and two equally sized enclosed arms with 40 cm high walls, arranged so
that the arms of the same type are opposite to each other. The junction of the four arms
formed a central square area (10 cm x 10 cm). The apparatus was made of black hard plastic
material and elevated to a height of 62 cm. On PND77, animals were allowed to freely explore
the maze for 5 min under dim red light conditions. Frequency and duration of open and
closed arm visits were separately recorded, with an arm visit being considered whenever an
animal entered it with their four limbs. Percentages of open arm entries and time spent in the
open arms were calculated as referred to total arm entries and total time in arms, respectively,
and were considered as the most relevant parameters related to anxiety. In turn, closed arm
entries were considered as an index of general motor activity [47, 48]. Animals that fall off the
EPM were not included in the statistical analysis. The animals that fall off the maze were dis-
tributed as follows: males: CoVh (3), CoLept (6), MDVh (3), MDLept (4); females: CoVh (1),
CoLept (2), MDVh (7) and MDLept (7). Although we did not record the risk taking behaviors,
we did observe that the animals that fall of the maze showed a high frequency of this type of
behaviors such as risk assessment with more than a half of the body out of the open arms
(especially MD females). Given the high frequency of these patterns, particularly in MD
females, we analyzed the frequency of falls from the EPM by a chi-squared test (see results).
As after excluding the animals fallen from the maze, in MD female groups there were no
enough animals from different litters to perform an ANCOVA, we decided to carry out this
analyses only in males.
Tissue collection
On PND90 all rats were sacrificed after a 12h fast by rapid decapitation and trunk blood was
collected in tubes and rapidly placed on ice and kept overnight at 4°. The blood was centrifuged
(3000 rpm for 15 min) and the serum collected and stored at −20° until processed and the
brain was rapidly removed. The hippocampus and frontal cortex were dissected. They were
then frozen in liquid nitrogen and stored at −80° until analyses. To avoid regional variability,
the left and right sides were alternated in both brain areas and for both protein and mRNA
determinations.
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Western Blotting
Tissue from six males and females per experimental group (2 animals/ litter/group), randomly
selected, was homogenized on ice in 300μl of radioimmunoprecipitation assay lysis buffer
(RIPA) with an EDTA-free protease inhibitor cocktail (Roche Diagnostics). After homogeniza-
tion, samples were left overnight at -80°C. The following day they were centrifuged at 14,000
rpm for 20 min at 4°C. Supernatants were transferred to a new tube and the protein concentra-
tion was estimated by Bradford protein assay.
In each assay the same amount of protein was loaded in all wells (10, 20 or 40 μg) depending
on the protein to be detected and resolved by using 8–12% SDS-acrylamide gels. After electro-
phoresis proteins were transferred to polyvinylidine difluoride (PVDF) membranes (Bio-Rad,
Hercules, CA, USA) and transfer efficiency was determined by Ponceau red dyeing. Membranes
were then blocked with Tris-buffered saline (TBS) containing 5% (w/v) bovine serum albumin
(BSA; Sigma-Aldrich, Schnelldorf, Germany) and incubated with the appropriate primary anti-
body. The antibodies employed included anti-NG2 (Sigma-Aldrich, St Louis, MO, USA), anti-
glial fibrillary acidic protein (GFAP; Sigma-Aldrich, St Louis, MO, USA), anti-PSD95 (Thermo
Scientific, Rockford, IL, USA), anti-neural cell adhesion molecule (NCAM; Millipore, Temecula,
CA, USA), anti-vimentin (Sigma-Aldrich, St. Louis, MO, USA) and anti-β actin (Thermo Scien-
tific, Cheshire, UK) were used at a concentration of 1:1000; anti-neuronal nuclei (NeuN; Milli-
pore, Temecula, CA, USA), anti-cannabinoid receptor type 1 (CB1; Sigma-Aldrich, St Louis,
MO, USA), anti-brain-derived neurotrophic factor (BDNF; Sta. Cruz biotechnology, Dallas, TX,
USA) and anti-glutamate aspartate transporter (GLAST; Alpha Diagnostic International, S.
Antonio, TX, USA) were used at a concentration of 1:500; and anti-synaptophysin (Sigma-
Aldrich, St Louis, MO, USA) was used at a concentration of 1:2000.
Membranes were subsequently washed and incubated with the corresponding secondary
antibody conjugated with peroxidase (1:2000; Pierce, Rockford, IL, USA). Bound peroxidase
activity was visualized by chemiluminescence and quantified by densitometry using an Image-
Quant LAS4000 mini TL Software (GE Healthcare Europe GmbH, Spain). All blots were rehy-
bridized with actin to normalize each sample for gel loading variability. All data are normalized
to control values on each gel.
For the statistical analyses we used between 5–6 males and females per experimental group
from 3 different litters (1–2 animals/litter/experimental group) and, in some cases, this number
of animals was adjusted to the amount of available sample.
Quantitative real-time PCR
Total RNA was extracted from the hippocampus and frontal cortex (alternating the left and
right side in both brain areas to avoid variability) of 6 males and females per experimental
group (2 animals/ litter/group), randomly selected, by using TRIzol1 Reagent (Invitrogen).
High Capacity cDNA Reverse Transcription kits (Applied Biosystems, Foster City, CA) were
used according to the manufacturer's protocol on a Peltier thermal Cycler Tetrad2 (BioRad) to
transcribe 2 μg total RNA isolated from each tissue.
Amplification of the cDNA template was performed with an ABI PRISM 7900HT sequence
Detection System (Applied Biosystems) using TaqMan Universal PCRMaster Mix (Applied
Biosystems) and TaqMan Gene Expression Assay kits for each detected gene (Applied Biosys-
tems). The commercial reference for each predesigned expression assay is as follows for each
gene measured in the hippocampus and frontal cortex: corticotropin-releasing hormone (CRH,
Rn01462137_m1), leptin receptor (LepR; Rn01433250_m1), insulin-like growth factor 1 (IGF1,
Rn99999087_m1) and insulin-like growth factor 1 receptor (IGF1R, Rn01477918_m1). Results
were normalized to actin (Rn00667869_m1) mRNA levels for both tissues.
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According to manufacturer's guidelines, the ΔΔCT method was used for relative quantifica-
tion. Statistics were performed using ΔCT values.
For the statistical analyses we used between 5–6 males and females per experimental group
from three different litters (1–2 animals/litter/experimental group). Samples that did not meet
the standards of purity and /or integrity were excluded
Leptin assay
Leptin was measured in duplicate by a multiplexed magnetic bead immunoassay kit (Millipore
Corporation), as previously described [49]. Briefly, beads conjugated to the appropriate anti-
body and serum samples (25 μl each) were incubated over night at 4°C with shaking. Wells
were washed three times using a wash buffer and antibody conjugated to biotin (50 μl) was
added. After incubation for 30 min at room temperature with shaking, beads were incubated
during 30 min with 50 μl streptavidin conjugated to phycoerythrin. Beads were analyzed in the
Bio-Plex suspension array system 200. Raw data (mean fluorescence intensity) were analyzed
using the Bio-Plex Manager Software 4.1 (Bio-Rad Laboratories). For the statistical analyses we
used 6 males and 6 females per experimental group from three different litters (2 animals/lit-
ter/experimental group), randomly selected.
Statistical analysis
In the case of the parameters measured by Western blotting or RT-qPCR, the usual criterion to
reduce litter effect in forming experimental groups, i.e., a maximum of 2 male and 2 female off-
spring from any given litter was fulfilled. Thus, for the analyses of the molecular parameters,
3-way ANOVA was used (with the 3 factors being: sex, MD and Leptin treatment), followed by
2-way ANOVA where appropriate i.e. in the presence of significant interaction between main
factors in the 3-way ANOVA. As in the behavioral tests there were more than 2 males/females
from the same litter in each experimental group, in this case we have controlled for litter effects
by performing ANCOVA analyses (including “litter” as covariate). Normality was checked by
Shapiro-Wilks’s test (p>0.05). The criterion of normally distributed data were not always met
in some populations under study and, so, when necessary, data were transformed by the Neper-
ian logarithm function, aiming to satisfy the assumption of normality for ANOVA. The Tukey
test was performed for post-hoc comparisons except when the criterion of homoscedasticity
(Levene test, p>0.05) was not met, in this case another more restrictive post-hoc comparison
test (Bonferroni test), was used to avoid a type I error. In the EPM, the frequency of events
(falls from the EPM) was analyzed with a chi-squared test. In all cases, P< 0.05 was considered
statistically significant. All statistical analyses were carried out with SPSS, version 19.0 (SPSS
Inc., Chicago, IL, USA).
Results
Behavioral testing
Main statistical results are shown in Table 1 and means ± SEMs are represented as histograms
in Figs 2 and 3.
Despite the litter significantly affected some of the behavioral parameters studied (Table 1),
the effects of our experimental factors (sex, MD, and leptin administration) remained signifi-
cant in most cases. Taken together, the significant effects here reported are confirmed since
they remain significant when correcting by the litter. The ANCOVA performed on the parame-
ters measured in the open field test revealed a significant effect of sex, with females showing
the lowest value for the percentage of internal ambulation; and the highest value for total
Extrahypothalamic Effects of Maternal Deprivation & Neonatal Leptin
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ambulation and rearing frequency. A main effect of MD on the percentage of internal ambula-
tion was found, with MD rats showing an increase in this value. Leptin treatment significantly
increased total ambulation and rearing frequency in MD rats (Fig 2).
In the elevated plus maze, where only males were analyzed by the ANCOVA (as indicated
in Material and Methods), the analysis did not reveal any significant difference among male
groups for % of open arm entries (CoVh: 52.00±6.14; CoLept: 33.38±8.39; MDVh: 45.04±3.56;
MDLept: 53.37±5.95; n = 6–9) or closed arm entries (CoVh: 9.44±0.84; CoLept: 8.17±0.75;
MDVh: 8.56±1.00; MDLept: 8.83±0.60; n = 6–9). It is worth mentioning that in this test, MD
females fall more often from the apparatus than MDmales (χ2(1) = 6.75, p<0.01), with 14 out
of 24 MD females falling from the EPM as opposed to 7 out of 22 MDmales.
In the novel object test, the analyses of the discrimination index, which indicates the work-
ing memory of the animals in the novel object test did not reveal any significant effect. A main
effect of sex on the discriminatory index (DI) was found, with females showing higher values
than males (Fig 3).
Synaptic plasticity markers. Protein levels
Main results obtained in the 3-Way ANOVA are shown in Table 2, and Fig 4 represent
mean ± SEM for the different experimental groups as well as significant differences derived
from post hoc comparisons.
NeuN. As Table 2 shows, the 3-Way ANOVA for hippocampal NeuN revealed two signifi-
cant double interactions sex x MD and MD x leptin. Two-way ANOVA split by MD revealed a
main effect of sex [F(1,18) = 7.87; p<0.05] and a double interaction between sex and leptin
treatment [F(1,18) = 15.71; p<0.005] in MD rats, without effects in Co groups. As Fig 4A
show, MDVh males tended to increase NeuN levels when compared to CoVh group (Tukey’s
post hoc, p = 0.1), and the leptin treatment reversed this trend, i.e., significantly decreased
NeuN levels of MDmales to control values (Tukey post hoc, p<0.05). Also, the figure shows a
sexual dimorphism between MDVh with females showing the lowest values (Tukey post hoc,
p<0.005).
No significant differences were found in the frontal cortex (Fig 4B)
Synaptophysin. The 3-Way revealed a significant effect of the leptin treatment as well as
significant sex MD interaction on the expression of hippocampal synaptophysin. Two-way















F1,83 p-value F1,83 p-value F1,83 p-value F1,78 p-value F1,78 p-value F1,25 p-value F1,25 p-value
Litter 9.29 <0.005 0.22 ns 4.09 <0.05 4.62 <0.05 4.88 <0.05 0.20 ns 8.03 <0.01
Sex 6.01 <0.05 15.21 <0.005 37.95 <0.005 8.78 <0.01 0.09 ns - - - -
MD 12.70 <0.005 0.31 ns 4.80 <0.05 3.48 ns 0.73 ns 0.19 ns 0.50 ns
Leptin 5.67 <0.05 0.23 ns 1.33 ns 0.40 ns 0.59 ns 2.61 ns 1.89 ns
Sex x MD 0.31 <0.05 0.05 ns 1.06 ns 0.04 ns 4.41 <0.05 - - - -
Sex x Leptin 0.27 ns 0.67 ns 0.50 ns 0.27 ns 0.03 ns - - - -
MD x Leptin 0.31 ns 8.34 <0.01 9.47 <0.005 0.53 ns 0.32 ns 0.94 ns 0.65 ns
Sex x MD x Leptin 1.97 ns 0.01 ns 0.01 ns 1.35 ns 0.71 ns - - - -
Main signiﬁcant results extracted from the three-way ANCOVA (litter was considered as a covariate factor). See material and methods section for details.
doi:10.1371/journal.pone.0137283.t001
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Fig 2. Open field test. (A) Emotionality index, calculated as the percentage of internal ambulation referred to
total ambulation, (B) total ambulation and (C) rearing frequency were registered in maternally deprived (MD)
or control (Co) male and female rats treated with leptin (Lept) or vehicle (Vh) from postnatal day (PND) 9 until
PND13 (n = 10–12). Post hoc test: *<0.05.
doi:10.1371/journal.pone.0137283.g002
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ANOVA split by sex revealed a main effect of MD in males [F(1,17) = 11.14; p<0.005] and in
females [F(1,16) = 5.16; p<0.05] with MDmales showing lower levels and MD females higher
levels than their respective control groups. Post hoc comparisons (Fig 4C) only revealed a sig-
nificant decrease in MDLept males comparing with CoLept males (Tukey post hoc, p<0.05).
No main effects were found in the frontal cortex (Fig 4D). However, there was a significant
interaction between MD and leptin treatment. Two-way ANOVA split by MD revealed an
effect of leptin treatment in MD (but not in Co) animals [F(1,20) = 5.72; p<0.05] As Fig 4D
shows, MDLept animals had lower synaptophysin levels than MDVh animals.
PSD95. The 3-way ANOVA for hippocampal PSD95 levels showed a significant interac-
tion between sex and leptin. Two-way ANOVA split by sex revealed an effect of leptin treat-
ment in both sexes (males: [F(1,19) = 6.65; p<0.05]; females: [F(1,16) = 5.22; p<0.05]). As Fig
4E shows, the leptin effect had an opposite direction in males and females, i.e., in males, leptin
modestly decreased PSD95 expression whereas in females leptin increased this parameter. Post
hoc comparisons showed a significant difference between MDVh and MD Lept females
(Tukey’s post hoc, p<0.01).
Fig 3. Novel object test (NOT). (A)Discrimination index (DI) and (B) time spent in exploration of the object
during the 30 second training session of maternally deprived (MD) or control (Co) male and female rats
treated with leptin (Lept) or vehicle (Vh) from postnatal day (PND) 9 until PND13 (n = 8–12).
doi:10.1371/journal.pone.0137283.g003
Table 2. Main statistical results corresponding to synaptic plasticity markers (protein levels).
HIPPOCAMPUS NeuN Synaptophysin PSD95 NCAM(140kDa) NCAM(180kDa) BDNF CB1
F1,35 (p-value) F1,33 (p-value) F1,35 (p-value) F1,39 (p-value) F1,36 (p-value) F1,40 (p-value) F1,37 (p-value)
Sex 1.54 (ns) 0.01 (ns) 0.34 (ns) 0.61 (ns) 5.84 (<0.05) 0.06 (ns) 6.36 (<0.05)
MD 0.04 (ns) 0.25 (ns) 3.47 (ns) 0.12 (ns) 0.04 (ns) 0.11 (ns) 0.09 (ns)
Leptin 0.14 (ns) 5.02 (<0.05) 0.31 (ns) 4.12 (<0.05) 1.07 (ns) 0.05 (ns) 1.24 (ns)
Sex x MD 5.36 (<0.05) 15.38 (<0.005) 0.12 (ns) 2.67 (ns) 0.01 (ns) 0.18 (ns) 7.87 (<0.01)
Sex x Leptin 14.84 (<0.005) 0.22 (ns) 11.61 (<0.005) 0.45 (ns) 0.07 (ns) 0.30 (ns) 9.81 (<0.005)
MD x Leptin 2.01 (ns) 2.68 (ns) 2.17 (ns) 0.51 (ns) 0.03 (ns) 0.01 (ns) 0.53 (ns)
Sex x MD x Leptin 1.37 (ns) 0.61 (ns) 2.55 (ns) 0.03 (ns) 0.63 (ns) 1.01 (ns) 0.10 (ns)
FRONTAL CORTEX F1,40 (p-value) F1,40 (p-value) F1,34 (p-value) F1,37 (p-value) F1,35 (p-value) F1,35 (p-value) F1,40 (p-value)
Sex 2.63 (ns) 2.76 (ns) 0.31 (ns) 9.55 (<0.005) 1.10 (ns) 3.89 (ns) 2.03 (ns)
MD 0.46 (ns) 0.97 (ns) 0.41 (ns) 2.50 (ns) 3.48 (ns) 0.01 (ns) 3.25 (ns)
Leptin 0.20 (ns) 0.98 (ns) 3.31 (ns) 17.58 (<0.005) 17.71 (<0.005) 0.52 (ns) 4.96 (<0.05)
Sex x MD 0.95 (ns) 0.15 (ns) 0.94 (ns) 0.55 (ns) 0.18 (ns) 0.06 (ns) 0.03 (ns)
Sex x Leptin 0.59 (ns) 1.32 (ns) 11.76 (<0.005) 4.03 (ns) 0.89 (ns) 0.08 (ns) 0.35 (ns)
MD x Leptin 1.48 (ns) 4.20 (<0.05) 0.01 (ns) 4.64 (<0.05) 0.32 (ns) 0.07 (ns) 3.40 (ns)
Sex x MD x Leptin 0.48 (ns) 0.01 (ns) 0.14 (ns) 0.17 (ns) 0.85 (ns) 0.14 (ns) 0.13 (ns)
Main signiﬁcant results extracted from the three-way ANOVA. See material and methods section for details.
doi:10.1371/journal.pone.0137283.t002
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Fig 4. Protein levels in the hippocampus (left column) and frontal cortex (right column) of NeuN (A &
B), synaptophysin (C & D), PSD95 (E & F), NCAM (G & H) and CB1 receptor (I & J) in maternally
deprived (MD) or control (Co) male and female rats treated with leptin (Lept) or vehicle (Vh) from
postnatal day (PND) 9 until PND13 (n = 5–6). Representative western blotting immunoassays of each
protein from tissue homogenates of each brain area are presented above each histogram. Post hoc test:
*<0.05, **<0.01, ***<0.005.
doi:10.1371/journal.pone.0137283.g004
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The results obtained for frontal cortex were similar to those of hippocampus. The 3-Way
ANOVA revealed a significant sex x leptin interaction and the 2-Way ANOVA split by sex
revealed a significant effect of leptin [F(1,17) = 9.92; p<0.05] only in females. As Fig 4F shows,
as in hippocampus, MD females treated with leptin showed the highest PSD95 levels.
NCAM. The 3-Way ANOVA for the two forms of NCAM in the hippocampus (Fig 4G)
revealed a significant effect of leptin for 140 kDa NCAM expression, with leptin treated ani-
mals showing a decreased expression of this protein. In the case of 180 kDa NACM, a main
effect of sex was observed with females showing higher values than males (Fig 4G).
In the frontal cortex (Fig 4H) a significant effect of leptin was found for both isoforms, so
that animals exposed to leptin during the neonatal period showed significantly increased expres-
sion of the two proteins. A general effect of sex was found for NCAM 140 kDa, with females
showing significantly higher levels than males. Also, in this isoform (NCAM 140 kDa) there was
a main effect of MD and a significant MD x leptin interaction. The Two-way ANOVA split by
MD revealed an effect of leptin treatment (an increase in protein expression) only in MD but
not in control animals [F(1,18) = 19.71; p<0.005]. Post hoc comparisons showed a significant
difference between MDLept and MDVh females (Tukey’s post hoc, p<0.005).
BDNF. The analysis of BDNF expression in the hippocampus [Males (CoVh: 100.0±9.2;
CoLept: 92.7±12.1; MDVh: 87.9±5.3; MDLept: 94.6±10.8) and Females (CoVh: 93.1±10.5;
CoLept: 97.1±4.6; MDVh: 100.3±9.9; MDLept: 91.1±10.9)] and in the frontal cortex [Males
(CoVh: 100.0±15.1; CoLept: 105.3±14.8; MDVh: 102.3±14.1; MDLept: 105.6±4.2) and Females
(CoVh: 122.6±17.7; CoLept: 126.1±6.0; MDVh: 112.8±16.3; MDLept: 128.8±15.6)] did not
reveal any significant difference.
CB1 cannabinoid receptor. The 3-Way ANOVA for hippocampal CB1 receptor expres-
sion revealed a main effect of sex and, as Fig 4I shows, there was a sex difference between
MDVh, males and females, with females showing the higher values (Tukey’s post hoc, p<0.05).
The 3-Way ANOVA also revealed significant interactions between sex and MD and sex and
leptin. Two-way ANOVA split by sex revealed main effects of MD [F(1,17) = 4.67; p<0.05]
and leptin treatment [F(1,17) = 8.69; p<0.01] only in females, and post hoc comparisons
showed a significant difference between CoVh and Co Lept (Tukey´s post hoc test, p<0.05),
with these latter females showing the lowest values (Fig 4I).
In the frontal cortex, the 3-Way ANOVA only revealed a main effect of leptin, with this
effect being observable only in control non deprived animals (Fig 4J).
In summary, in the parameters described in this section, the hippocampus appeared to be
more susceptible to the effects of the treatments than the frontal cortex and the vast majority of
the effects were sex-dependent. Hippocampal NeuN, synaptophysin and CB1 were affected by
both MD and leptin, whereas PDD95 and NCAM were mainly affected by the neonatal leptin
treatment. In the frontal cortex the parameter most affected by the treatment was NCAM.
mRNA levels
Main results obtained in the 3-Way ANOVA are shown in Table 3 and Fig 5 represent
mean ± SEM for the different experimental groups as well as significant differences derived
from post hoc comparisons.
IGF1 and IGF1R. The 3-Way ANOVA for IGF1 mRNA levels in the hippocampus
revealed main effect of sex and MD as well as a significant triple interaction sex x MD x. As Fig
5A MD significantly increased the expression of IGF1 mRNA in males (Bonferroni’s pot hoc,
p<0.005) and the neonatal leptin treatment reversed this effect (Bonferroni’s pot hoc,
p<0.005). The analyses of IGF1R mRNA levels in the hippocampus revealed main effects of
sex and leptin treatment, as well as a triple interaction sex x MD x leptin. As Fig 5B shows, MD
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tended to increase IGF1R mRNA levels in males (Tukey’s post hoc, p = 0.057), whereas the lep-
tin treatment counteracted this trend (Tukey’s post hoc, p<0.005).
In the frontal cortex, the 3-Way ANOVA for IGF1 mRNA levels revealed a main effect of
MD and significant interactions between sex x MD and MD x leptin treatment. Two-way
ANOVA split by sex showed a significant effect of MD effect in males [F(1,17) = 8.05; p<0.05]
and a significant effect of leptin treatment in females [F(1,18) = 8.84; p<0.01]. As Fig 6A
shows, MD decreased IGF1 mRNA expression in control non deprived males while females
exposed neonatally to leptin showed increased IGF1 mRNA levels. The analyses of IGF1R
Table 3. Main statistical results corresponding to mRNA levels.
HIPPOCAMPUS IGF1 IGF1R CRH LepR
F1,37 (p-value) F1,34 (p-value) F1,37 (p-value) F1,39 (p-value)
Sex 8.66 (<0.01) 8.24 (<0.01) 9.63 (<0.005) 3.14 (ns)
MD 4.91 (<0.05) 1.97 (ns) 2.14 (ns) 1.23 (ns)
Leptin 1.53 (ns) 15.17 (<0.005) 8.45 (<0.01) 2.74 (ns)
Sex x MD 0.01 (ns) 1.97 (ns) 3.23 (ns) 0.05 (ns)
Sex x Leptin 0.01 (ns) 2.40 (ns) 1.60 (ns) 0.58 (ns)
MD x Leptin 1.28 (ns) 2.51 (ns) 2.60 (ns) 0.68 (ns)
Sex x MD x Leptin 14.59 (<0.005) 5.40 (<0.05) 3.33 (ns) 5.69 (<0.05)
FRONTAL CORTEX F1,35 (p-value) F1,36 (p-value) F1,38 (p-value) F1,34 (p-value)
Sex 2.30 (ns) 2.18 (ns) 1.04 (ns) 3.21 (ns)
MD 5.95 (<0.05) 11.20 (<0.005) 14.16 (<0.005) 0.35 (ns)
Leptin 0.93 (ns) 0.29 (ns) 0.01 (ns) 5.41 (<0.05)
Sex x MD 3.59 (ns) 0.26 (ns) 0.36 (ns) 0.01 (ns)
Sex x Leptin 8.45 (<0.01) 3.42 (ns) 1.74 (ns) 1.52 (ns)
MD x Leptin 4.10 (<0.05) 13.10 (<0.005) 1.21 (ns) 0.04 (ns)
Sex x MD x Leptin 1.10 (ns) 0.02 (ns) 0.44 (ns) 1.77 (ns)
Main signiﬁcant results extracted from the three-way ANOVA. See material and methods section for details.
doi:10.1371/journal.pone.0137283.t003
Fig 5. Expression levels in the hippocampus and frontal cortex of the mRNAs encoding insulin-like growth factor 1 (IGF1) (A), IGF1 receptor
(IGF1R) (B), corticotropin-releasing hormone (CRH) (C) and leptin receptor (LepR) (D) in maternally deprived (MD) or control (Co) male and female
rats treated with leptin (Lept) or vehicle (Vh) from postnatal day (PND) 9 until PND13 (n = 5–6). Post hoc test: ***p<0.005.
doi:10.1371/journal.pone.0137283.g005
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Fig 6. Protein levels in the hippocampus (left column) and frontal cortex (right column) of GFAP (A & B), vimentin (C & D), NG2 (E & F) and GLAST
(G & H) in maternally deprived (MD) or control (Co) male and female rats treated with leptin (Lept) or vehicle (Vh) from postnatal day (PND) 9 until
PND13 (n = 5–6). Representative western blotting immunoassays of problem protein from tissue homogenates of each brain area are presented above each
histogram. Post hoc test: *<0.05, **<0.01, ***<0.005.
doi:10.1371/journal.pone.0137283.g006
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mRNA levels in the frontal cortex rendered a main effect of MD and a significant interaction
between MD and leptin. Two-Way ANOVA split by leptin confirmed that the effect of MD
was only significant in the groups treated with vehicle [F(1,20) = 5.06; p<0.05] and not in
those receiving the neonatal leptin treatment (Fig 5B)
CRH. The 3-Way ANOVA for hippocampal CRH mRNA levels revealed significant main
effects of sex and leptin treatment. As a whole, females showed lower CRH mRNA levels than
males and the leptin treatment decreased CRHmRNA levels except in MD females (Fig 5C).
As for the frontal cortex, a main effect of MD was found. As Fig 5C shows, MD animals had
lower values than control non deprived ones.
Leptin receptor. The 3-Way ANOVA for hippocampal leptin receptor (LepR) mRNA
showed a triple interaction between sex, MD and leptin treatment but the Bonferroni’ post hoc
and Two-way ANOVA split by sex did not reveal any significant effect. In the frontal cortex a
main effect of the leptin treatment was found. As Fig 5D shows, leptin treated animals showed
increased levels of mRNA LeptR expression, except CoVh animals.
In summary, in the Hippocampus, leptin treatment reversed the effect of MD which
increased the levels of IGF1 mRNA in males. In frontal cortex MD decreased IGF1 mRNA and
this effect was not reversed by leptin. The pattern of changes of IGF1 was similar to those of
IGF1R within each region. In the hippocampus, leptin treatment decreased CRHmRNA
expression, whereas in the frontal cortex, MD diminished this parameter. In the frontal cortex,
leptin treatment increased leptin receptor mRNA levels
Protein levels of glial markers
Main results obtained in the 3-Way ANOVA are shown in Table 4 and Fig 6 represent
mean ± SEM for the different experimental groups as well as significant differences derived
from post hoc comparisons.
GFAP. The 3-Way ANOVA showed a significant triple interaction sex x MD x leptin for
hippocampal GFAP protein expression. As Fig 6A shows, MD decreased GFAP levels in males
(Tukey’s post-hoc, p<0.05) whereas the leptin treatment tended to reverse this effect.
In the frontal cortex, the 3-Way ANOVA showed main effect of sex and MD and the three
double interactions were also significant. Two-way ANOVA split by sex revealed an interaction
between MD and leptin [F(1,18) = 13.84; p<0.005] in males. As Fig 6B shows, MD significantly
decreased GFAP levels in this sex (Tukey’s pot-hoc, p<0.05), whereas the leptin treatment
counteracted this effect (Tukey’s pot-hoc, p<0.005). In females, a MD effect was found [F
(1,18) = 10.65; p<0.005], with MD females showing decreased GFAP levels.
Vimentin. The 3-Way ANOVA for hippocampal vimentin expression revealed the follow-
ing significant interactions: sex x MD, MD x leptin treatment and sex x MD x leptin. As Fig 6C
shows, MD significantly reduced vimentin levels in females (Tukey’s post hoc, p<0.05)
whereas the neonatal leptin treatment reversed this effect (Tukey’s post hoc, p<0.05).
The results were similar in the frontal cortex where 3-Way ANOVA showed significant
double interactions sex x MD and MD x leptin. Two-way ANOVA split by sex revealed a MD
effect [F(1,19) = 12.31; p<0.005] and a double interaction between MD and leptin [F(1,19) =
5.01; p<0.05] in females. As Fig 6D shows, MD significantly reduced vimentin expression in
females (Tukey’s post hoc, p<0.005), whereas leptin attenuated this effect.
NG2. The 3-Way ANOVA for hippocampal NG2 levels showed main effects of sex
(females higher expression than males) and leptin treatment as well as a double interaction
between sex and MD. According to this interaction, the 2-Way ANOVA split by sex revealed
opposite effects MD in both sexes, a decrease of NG2 levels in males [F(1,20) = 5.86; p<0.05]
and an increase in females [F(1,19) = 4.71; p<0.05]. In turn, an effect of the neonatal leptin
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treatment was found only in males, with treated animals showing an increase on NG2 levels [F
(1,20) = 6.31; p<0.05]. As Fig 6E shows, there was a sexual dimorphism in MD animals since
MDVh females and MDLept females have higher levels than MDVh (Tukey’s post hoc,
p<0.01) and MDLeptin males (Tukey’s post hoc, p<0.005), respectively.
In the frontal cortex, the analysis of NG2 levels revealed a significant triple interaction sex x
MD x leptin, as well as two significant double interactions sex x MD and MD x leptin. Fig 6F
shows sexual dimorphisms among CoVh and MD Vh animals (Tukey’s post hoc, p<0.05 in
both cases). The most interesting result is the effect of MD in females (decreasing NG2 levels)
(Tukey’s post hoc, p<0.005) and the fact that leptin treatment attenuated this effect.
Glutamatergic receptor. The 3-Way ANOVA performed on the hippocampal levels of
GLAST (Fig 6G). only revealed a significant sex x leptin interaction, and the 2-Way ANOVA
split by leptin revealed a sex effect [F(1,20) = 6.50; p<0.05] in Vh but not leptin treated groups
(females Vh showed higher levels than males Vh). In the frontal cortex, the 3-Way ANOVA
revealed a significant interaction between sex and MD. Two-way ANOVA split by sex revealed
that, in males, MD increased GLAST expression [F(1,20) = 5.99; p<0.05] whereas neonatal lep-
tin attenuated this effect. On the other hand, MD induced a decrease in GLAST expression in
the frontal cortex of females [F(1,20) = 5.29; p<0.05] and this effect was not attenuated by the
leptin treatments (see Fig 6H for post hoc significant differences).
In summary, once more the effects observed on glial markers and GLAST were sex depen-
dent. In both regions GFAP expression was decreased by MD in males and this effect was either
reversed or attenuated by the neonatal leptin treatment, similar changes were found for vimen-
tin and NG2, but in these cases in females. Cortical GLAST expression was differently affected
in males and females.
Leptin levels
The 3-Way ANOVA for leptin levels showed a significant effect of sex [F(1,40) = 6.27;
p<0.05]. Males: CoVh: 4.05±0.87; CoLeptin:3.16±0.76; MDVh:2.99±0.65; MDLeptin:2.88
Table 4. Main statistical results corresponding to glial markers (protein levels).
HIPPOCAMPUS GFAP Vimentin NG2 GLAST
F1,36 (p-value) F1,36 (p-value) F1,39 (p-value) F1,40 (p-value)
Sex 0.69 (ns) 0.74 (ns) 31.02 (<0.005) 2.76 (ns)
MD 0.01 (ns) 0.20 (ns) 0.11 (ns) 3.12 (ns)
Leptin 0.53 (ns) 0.13 (ns) 5.96 (<0.05) 0.03 (ns)
Sex x MD 0.42 (ns) 26.86 (<0.005) 10.26 (<0.005) 0.34 (ns)
Sex x Leptin 0.81 (ns) 0.51 (ns) 0.30 (ns) 4.83 (<0.05)
MD x Leptin 2.18 (ns) 5.92 (<0.05) 0.05 (ns) 1.63 (ns)
Sex x MD x Leptin 4.86 (<0.05) 9.79 (<0.005) 0.02 (ns) 0.01 (ns)
FRONTAL CORTEX F1,36 (p-value) F1,37 (p-value) F1,35 (p-value) F1,40 (p-value)
Sex 6.17 (<0.05) 0.08 (ns) 0.63 (ns) 1.80 (ns)
MD 8.57 (<0.01) 2.23 (ns) 2.56 (ns) 0.38 (ns)
Leptin 0.95 (ns) 1.29 (ns) 0.03 (ns) 0.07 (ns)
Sex x MD 4.64 (<0.05) 6.08 (<0.05) 13.50 (<0.005) 9.26 (<0.005)
Sex x Leptin 4.16 (<0.05) 0.20 (ns) 0.42 (ns) 1.70 (ns)
MD x Leptin 8.67 (<0.01) 5.77 (<0.05) 6.65 (<0.05) 2.38 (ns)
Sex x MD x Leptin 2.98 (ns) 0.02 (ns) 5.09 (<0.05) 2.03 (ns)
Main signiﬁcant results extracted from the three-way ANOVA. See material and methods section for details.
doi:10.1371/journal.pone.0137283.t004
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±0.64. Females: CoVh:1.93±0.23; CoLeptin:2.12±0.29; MDVh:2.44±0.56; MDLeptin:1.65±0.31.
N = 6 in all groups
Discussion
The main results of this study can be summarized as follows: 1) MD females appeared to show
an increased impulsivity or reduce “fear” 2) As opposed to previous studies, MD did not cause
a deficit in working memory, 3) Neonatal leptin treatment reversed or attenuated the effects of
MD in some of the parameters analyzed (e.g., mRNA expression of hippocampal IGF1 and
IGF1R and protein expression of GFAP and vimentin) partially confirming our hypothesis; 4)
The neonatal leptin treatment exerted a number of behavioral and neural effects that, in some
cases, differently affected MD and control non MD animals (e.g., rearing frequency, expression
of the following proteins: NeuN, PSD95, NCAM, CB1, NG2 and mRNA expression of IGF1
and IGF1R, CRH and LeptR); and 5) The vast majority of the effects caused by the treatments
appeared to be sex and region-dependent.
Leptin signalling during the neonatal leptin surge, which peaks approximately at PND 9–10,
has been shown to play a crucial role in the development of neuroendocrine circuits involved
in metabolic control, particularly in the hypothalamus [50]. Leptin receptors are highly
expressed in extra-hypothalamic brain regions and evidence is growing to indicate that leptin
can regulate hippocampal synaptic function and influence many central processes including
cognition. Moreover, several animal studies using adult leptin administration, as well as
human studies, suggest that leptin is involved in the regulation of emotional behavior and neu-
ropsychiatric disorders [34, 51]. In spite of these findings, there is scarce information about the
programming effects of the neonatal leptin surge on the development of hippocampus and
frontal cortex that are highly relevant for emotional control and cognitive function.
During the last years we have shown that rats deprived from their mothers during 24 h at
PND 9 (coincident with the physiological leptin surge), MD animals, show a marked reduction
in their leptin levels not only during the period of maternal separation but also afterwards,
until PND 13 and even in the adulthood [26, 27]. These MD rats also show alterations in their
developing hippocampus and frontal cortex, as well as behavioural modifications affecting
their emotional status and cognitive function [16]. We hypothesised that the lack of appropri-
ate neonatal leptin signalling in these MD animals could contribute to their neurodevelopmen-
tal alterations. To test this hypothesis, we have treated male and female animals with leptin
during the critical days for leptin’s organizational effects (PND 9–13) and analysed their behav-
iour, hippocampus and cerebral cortex in the adulthood.
Behavioral tests
In the open field, MD caused an increase in the percentage of internal ambulation in females
which indicates a decreased “fear” for the open spaces (an anxiolytic-like effect). In the elevated
plus maze, these same animals (MD females) showed an abnormally increased falls from the
maze, and this occurred because these animals displayed a marked risk-taking behavior (such
as rearing in open arms and peer into the void with more than half of the body outside the
maze). It is known that leptin plays a role in depression- and anxiety- related behaviors. Indeed,
administration of leptin (1 mg/kg ip) in adult rats [52] and mice [53] produces an antidepres-
sant effect. In addition, there is evidence that leptin has anxiolytic-like properties, which can be
observed in social interactions of mice after acute leptin administration [53]. The results
reported here indicate that early modification of leptin levels might have long term emotional
effects, which emphasizes the neuroprogramming effect of neonatal leptin signaling outside of
the hypothalamus. In the open field test, leptin treatment increased the total ambulation and
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rearing frequency only in MD rats; thus, in this case MD appears to be a factor of vulnerability
for the effect of leptin. There was a clear sexual dimorphism in these behavioral responses,
since females showed more motor and exploratory activity than males, a finding that is in
agreement with most of the literature (46–48).
Regarding cognition, no effect of MD was found in the novel object test. However, we have
previously reported that both, adolescent MD (14) and adult MD animals [12] have a decreased
discrimination index in this test, i.e., an impaired memory function. It is important to point out
that the animals used in this study were injected several days during the neonatal critical period
and this manipulation may have somehow protected the MD animals from the above men-
tioned changes. For example, neonatal handling, could have induced some resilience to the neg-
ative impact the MD protocols by increasing the quality and quantity of maternal care once the
pups are returned to their mothers after the injection (handling) protocol [54]. In previous stud-
ies [18], we found that licking-grooming frequency was increased by MD during PND10 (after
returning the pups to the dam). This is important because it has been proposed that an increase
in maternal care may buffer or compensate the negative consequences of long mother/pup sepa-
rations [55]. However, we have seen in many previous studies that the effects of this particular
MD protocol are present [40], therefore, it is very likely that, in the present study, the absence of
some of the effects of MD is rather attributable to the stress of injections. In this test a sexual
dimorphism was found with females showing a greater discrimination index than males.
Protein levels of synaptic plasticity markers
MD has been reported to notably affect several molecules implicated in synapses formation
and stabilization [16]. In this study we found two significant interactions, i. e., sex x MD and
sex x leptin, affecting hippocampal NeuN (MD increased the expression of this protein in
males) and hippocampal synaptophysin, with MDmales showing lower levels and MD females
showing higher levels than their respective control groups. In a previous study on adolescent
rats of both sexes, we found that MD decreased the expression of plasticity markers in the hip-
pocampus and frontal cortex, including NeuN, BDNF, PSD95, synaptophysin and NCAM lev-
els, and caused impaired recognition memory in the novel object test (NOT) [15]. We also
previously found that adult MD animals showed impaired memory and changes in markers of
synaptic plasticity in the hippocampus (mRNA levels of BDNF and synaptophysin) [12].
Moreover, a decrease in BDNF (mRNA and protein levels) was described in the hippocampal
formation of adult male MD animals, although BDNF abnormalities exclusively appeared after
weaning (PND21) [56]. Thus, we believe that, as previously indicated, the manipulation (daily
injections from PND9 to PND 13) may have masked some of the potential MD effects, for
example the lack of effect on BDNF in the present MD rats may be related with the lack of
effect on their memory function. This interpretation is supported by the lack of effects of MD
on leptin levels since in previous studies where early neonatal injections were not performed,
we observed that MD diminished leptin levels in adulthood [12, 25]. However, as in previous
studies, we did find, as expected, a sexual dimorphism [12, 25], with males having higher leptin
levels than females.
Interestingly, we also observed several sex dependent effects of the neonatal leptin treatment
on the above mentioned neural and synaptic plasticity markers. In particular leptin treated
females showed an increase of NeuN expression in their hippocampus. This result is in agree-
ment with previous in vivo and in vitro studies showing that leptin stimulates adult neurogen-
esis through direct receptor activation on newly formed neurons in the hippocampus and
hypothalamus [57] and that leptin deficiency (ob/ob or db/db models) provokes neurodegen-
eration in frontal cortex and hippocampus. Leptin treated females also showed a significant
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decrease in hippocampal CB1 receptors expression. General effects of leptin consisting in a
reduction of hippocampal synaptophysin and NCAM (140 KDa) levels, were also found, which
together suggests decreased synapses possibly due to impaired synaptogenesis. On the other
hand, in the cortex leptin increased PSD95 in females and NCAM and CB1 in both sexes. It is
likely that, at least in relation to some of the parameters analyzed, the dose of leptin used has
resulted in an excess of leptin during the neonatal period leading to disruption of synaptogen-
esis which manifests as an altered profile of synaptic plasticity markers in adulthood. The
nature of these changes is mainly sex dependent, possibly reflecting differential temporal and/
or functional developmental profiles in males and females. In general, leptin tended to decrease
the parameters analyzed in hippocampus and increase them in the frontal cortex.
Given the increasing interest in the study of endocannabinoid system, it is worth emphasiz-
ing the importance of the CB1 cannabinoid receptor in the context of this study. The CB1
receptor is crucial for brain development and synaptic plasticity, as well as for the regulation
and response to stress. We have repeatedly found clear short and long-term effects of MD on
several components of the endocannabinoid system, including the CB1 receptor [16]. Under
the present conditions, we observed modest effects of MD on hippocampal CB1 protein
expression, but the neonatal leptin treatment significantly decreased CB1 expression in the hip-
pocampus of females and increased cortical CB1 expression in both sexes. The relationship
between leptin and the endocannabinoid system has been mainly analyzed in the context of
energy homeostasis and in the hypothalamus [58]. Less is known regarding cannabinoid-leptin
interactions in extra-hypothalamic areas, but given the pleiotrophic nature of both systems, it
is very likely that they are involved in functions beyond energy homeostasis. Our results indi-
cate that a deregulation of the postnatal leptin surge, due to a deficiency or an excess, has a
long-term effect on the expression of CB1 receptor.
mRNA expression of gens related with leptin and stress
The IGF system plays a central role in brain development and plasticity [59, 60] and one of its
effects in the brain is to protect neurons from apoptosis [60]. In fact, we have shown in previ-
ous studies how MDmodulates mRNA levels of IGF1 and its receptor in the hypothalamus
[26]. For this reason, we studied this parameter here. Moreover, leptin modulates cell prolifera-
tion and differentiation [61], so we expected to find an effect of the neonatal leptin treatment.
The expression of mRNA for IGF1 and its receptor increased in the hippocampus of MDVh
males and neonatal leptin reversed these effects, whereas no effects of MD were found in Vh
females in this area. In contrast, in the frontal cortex, MDVh males had a decreased expression
of cortical IGF1 and IGF1R and these effects were not reversed by leptin. Thus, both, the effect
of MD and the ability of leptin to reverse the effect of this neonatal stress is sex dependent.
Leptin tended to decrease the expression of mRNA for IGF1 and its receptor, with the
exception of the frontal cortex in females. IGF-1 has been described as a potential biomarker
for mood disorders [62] and, as indicated above, leptin has also been implicated in anxiety and
depression related responses [34]; thus, it is possible that leptin and IGF-1 interact in the regu-
lation of central nervous system functions.
One of the striking characteristics of prolonged maternal separation is the profound activa-
tion of the HPA. Down-regulation of CRHmRNA has been observed in mice exposed during 8
h to maternal separation, an effect which suggests direct modulation of the neonatal HPA axis
[63]. Here we found that MD induced a long-term decrease in CRH mRNA levels in the frontal
cortex of vehicle treated males and females. We found that this MD protocol markedly
increases the levels of corticosterone (CORT) and this is evident at both PND10 and PND 13
[64]. It is plausible that this marked surge of CORT in this critical neonatal period programs
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HPA functioning. However, we cannot rule out that the neonatal Vh injections have changed
the corticosterone response in MD rats. The neonatal leptin treatment induced a long-term
decrease in hippocampal CRHmRNA levels in control non MD animals of both sexes and in
MDmales. Leptin feeds back to the hypothalamus to inhibit CRH release [34], so it is possible
that it acts in a similar way in other brain regions. In the hippocampus of females the combina-
tion of MD and leptin treatment tended to normalize CRH mRNA levels, suggesting a complex
interaction between the two treatments.
Finally, neonatal leptin treatment induced a long term effect on leptin receptor mRNA expres-
sion increasing this parameter in males and females (with the exception of control Vh males).
Protein levels of glial markers
Leptin plays an important role in glial development [38, 39, 65] and we have previously found
that MD also affects glial cells development [16]. Under the present experimental conditions,
the expression of the astrocyte marker GFAP decreased in both brain regions in MDmales and
in the frontal cortex of females. Leptin treatment reversed the MD effects in males, but not in
females. The other astrocyte marker analyzed, vimentin, was also decreased in the hippocam-
pus and frontal cortex of MD females, and in these cases (especially in the hippocampus) neo-
natal leptin treatment reversed this effect. As early stress induces cell death [66], in view of the
decrease in glial markers, it is plausible that MDmight have induced glial death. On the other
hand, leptin is implicated in brain progenitor cell proliferation and astrocyte differentiation in
the hypothalamus [67]. Moreover, astrocytic and neuronal leptin signaling interacts with each
other in the execution of normal and pathophysiological functions in extrahypothalamic brain
areas such as the hippocampus and frontal cortex [68]. The present data point to an efficient
protective effect of the leptin treatment in MD animals and suggest a clear interaction between
both MD and neonatal leptin exposure. The potential clinical utility of leptin through its mod-
ulation of neuron-glia interaction remains to be determined.
MD females also showed decreased expression of the oligodendrocyte precursor NG2 in
their frontal cortex, with this effect being partially counteracted by neonatal leptin. In line with
this finding, an increase in the rate of cell death, mostly of oligodendrocytes in white matter
tracts, was observed by Zhang et al. (2002) following a similar protocol of early life stress (MD
at PND 11). There was also a clear sex difference in the frontal cortex between the CoVh
groups, with females showing higher levels of NG2.
GLAST expression is altered in pathological conditions, such as hypoxia/ischemia, multiple
sclerosis, schizophrenia and epilepsy. In general, activity of this glutamate transporter is con-
sidered to be responsible for termination of glutamatergic transmission and for the prevention
of excitotoxic damage [69]. Stress leads to glutamate release in the hippocampus [70], and
over-activation can put the neuron at risk of excitotoxicity [71, 72]. Pickering et al. (2006)
found an increase in GLAST expression in the hippocampus of MDmales (360 min of daily
maternal deprivation during PND1-21). Here we show an increase in GLAST protein expres-
sion in the frontal cortex of MDmales that tended to be compensated by the neonatal leptin
treatment, whereas the opposite was found in females, i.e., a modest decrease in GLAST frontal
cortex expression in all MD females. Since GLAST is found mainly in astrocytes and other glial
cells [73, 74], this decrease of GLAST expression in MD females might be related to their
diminished expression of the markers of glial cells.
Conclusions
In summary, in some but not all of the parameters analyzed, the neonatal leptin treatment
reversed the effects of MD, partially confirming our hypothesis. In those cases where the leptin
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treatment did not reverse the effects of MD, the reason might be that MD is a complex neonatal
stress involving not only a marked decrease of leptin levels, but also an increase in corticoste-
rone and a decrease in glucose levels [40]. In fact, MD involves lack of social contact with the
mother, lack of milk ingestion, dehydration and hypothermia, all of which could be involved in
the long-term consequences.
We found that some of the previously observed effects of this neonatal stress were not
found this study. We propose that the stress of the injections administered during the critical
neonatal period may have exerted a protective effect (or could have changed the “baseline” in
the controls). This hypothesis opens new questions regarding the interaction of different
manipulations or events during early life.
The neonatal leptin treatment, per se, exerted a number of effects on synaptic plasticity
markers. The data support the hypothesis that the neonatal leptin surge plays an important
role in the development of extrahypotalamic areas and that an adequate leptin level, avoiding
both excess and deficiency, appears to be necessary for its correct neuroprograming effect.
These concepts may have clinical implications and deserve to be studied further in the future
[34]. A potential clinical application of leptin should evaluate the optimal level required
depending on the age and sex of the individual and should also consider that the effect of leptin
may be region dependent.
The data presented revealed diverse sexual dimorphisms that are probably due to the orga-
nizational effects of perinatal gonadal hormones during a critical period of brain sexual differ-
entiation [75, 76], and/or to their organizational effects and the activation they produce during
the peri-adolescent period [77, 78]. Another complementary factor that may contribute to the
sex differences observed is the different neurodevelopmental stage of males and females at the
ages when the treatments are performed [79].
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